Medacta Group SA (MOVE) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.172x

Based on the latest financial reports, Medacta Group SA (MOVE) has a cash flow conversion efficiency ratio of 0.172x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF72.95 Million ≈ $92.23 Million USD) by net assets (CHF424.61 Million ≈ $536.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Medacta Group SA - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Medacta Group SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Medacta Group SA debt and liabilities for a breakdown of total debt and financial obligations.

Medacta Group SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medacta Group SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Guangdong Dongfang Precision Science & Technology Co Ltd SHE:002611	0.059x
Hawkins Inc NASDAQ:HWKN	0.069x
Community Bank System Inc NYSE:CBU	0.042x
Seacoast Banking Corporation of Florida NASDAQ:SBCF	0.010x
Sunrun Inc NASDAQ:RUN	0.019x
Quilter PLC JSE:QLT	0.318x
Lakala Payment Co Ltd SHE:300773	0.048x
Telefonaktiebolaget LM Ericsson (publ) ST:ERIC-A	0.150x

Annual Cash Flow Conversion Efficiency for Medacta Group SA (2016–2024)

The table below shows the annual cash flow conversion efficiency of Medacta Group SA from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Medacta Group SA worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CHF379.66 Million ≈ $480.00 Million	CHF107.14 Million ≈ $135.46 Million	0.282x	+23.97%
2023-12-31	CHF330.04 Million ≈ $417.26 Million	CHF75.13 Million ≈ $94.98 Million	0.228x	-14.95%
2022-12-31	CHF274.65 Million ≈ $347.24 Million	CHF73.51 Million ≈ $92.94 Million	0.268x	+12.08%
2021-12-31	CHF226.40 Million ≈ $286.23 Million	CHF54.06 Million ≈ $68.35 Million	0.239x	-34.00%
2020-12-31	CHF164.72 Million ≈ $208.25 Million	CHF59.59 Million ≈ $75.34 Million	0.362x	+4.57%
2019-12-31	CHF123.23 Million ≈ $155.80 Million	CHF42.63 Million ≈ $53.90 Million	0.346x	-53.60%
2018-12-31	CHF89.07 Million ≈ $112.61 Million	CHF66.41 Million ≈ $83.96 Million	0.746x	+46.94%
2017-12-31	CHF101.67 Million ≈ $128.54 Million	CHF51.59 Million ≈ $65.22 Million	0.507x	+32.33%
2016-12-31	CHF146.87 Million ≈ $185.69 Million	CHF56.31 Million ≈ $71.19 Million	0.383x	--

About Medacta Group SA

SW:MOVE Switzerland Medical Devices

Market Cap

$3.57 Billion

CHF2.82 Billion CHF

Market Cap Rank

#4868 Global

#72 in Switzerland

Share Price

CHF141.60

Change (1 day)

-0.98%

52-Week Range

CHF130.20 - CHF176.00

All Time High

CHF176.00